RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Monday reported fourth-quarter net income of $111.9 million, after reporting a loss in the same period a year earlier.
The Ramsey, New Jersey-based company said it had profit of 46 cents per share. Earnings, adjusted for non-recurring gains, came to 14 cents per share.
The infectious disease drug developer posted revenue of $117.5 million in the period.
For the year, the company reported net income of $197.7 million, or 81 cents per share, swinging to a profit in the period. Revenue was reported as $426.5 million.
Adma Biologics shares have dropped nearly 8% since the beginning of the year. In the final minutes of trading on Monday, shares hit $15.83, nearly tripling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
